AFF008E: Observational Phase 1b Follow-up Extension Study for Patients With Parkinson's Disease After Immunization With AFFITOPE® PD01A
CompletedOBSERVATIONAL
Enrollment
30
Participants
Timeline
Start Date
June 30, 2013
Primary Completion Date
February 28, 2015
Conditions
Parkinson's Disease
Trial Locations (1)
1080
Studienzentrum der PROSENEX, AmbulatoriumbetriebsgesmbH an der Confraternität-Privatklinik Josefstadt, Skodagasse 32, Vienna
All Listed Sponsors
lead
Affiris AG
INDUSTRY
NCT01885494 - AFF008E: Observational Phase 1b Follow-up Extension Study for Patients With Parkinson's Disease After Immunization With AFFITOPE® PD01A | Biotech Hunter | Biotech Hunter